This is a $1,327,640.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract is for "COORDINATION AND TECHNICAL SUPPORT" under NIAID's program for "PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES". IAVI, as the prime contractor, will provide a...
This federal contract award was issued by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to International AIDS Vaccine Initiative Inc. (IAVI), a non-profit organization. The one-year, $105,353 cost-plus-fixed-fee contract supports IAVI's product development plans to advance HIV vaccine manufacturing efforts. This award does not utilize a set-aside designation. IAVI provides a range of research,...
This is a $177,790.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract is for COORDINATION AND TECHNICAL SUPPORT services under NIAID's PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES major program. This contract is not designated as a set-aside. IAVI, as the prime contractor, will provide a range of research,...
This $8,398,301.00 cost-reimbursement delivery order was awarded on December 1, 2021 by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The award is part of NIAID's Preclinical And Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS) program and will support IAVI's preclinical and translational vaccine development work for HIV and other infectious diseases through...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the International AIDS Vaccine Initiative (IAVI), a non-profit organization. The contract has a total ceiling value of $4,687,192.00 and is a delivery order under IAVI's existing indefinite delivery/indefinite quantity (IDIQ) contract with NIAID for preclinical services supporting the development of biopharmaceutical products, including vaccines, for infectious diseases....
This federal contract award, valued at $3,170,861.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization focused on the development of HIV vaccines. The contract provides for coordination and technical support services to advance the development of HIV vaccines and other infectious disease products. The contract is a delivery order issued under an Indefinite...
This federal contract award, valued at $1,707,175.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract supports process development for cell culture, upstream and downstream processes in the production of HIV-1 biomolecules, as part of NIAID's broader program for process and analytical support in the...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $432,452.00 cost-plus-fixed-fee delivery order contract to the International AIDS Vaccine Initiative (IAVI), a non-profit organization, for a feasibility assessment of HIV envelope protein antigens. The contract does not have a set-aside designation. IAVI has conducted research, development, and advocacy to advance vaccines and antibodies for infectious...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization. The $978,729.00 cost-plus-fixed-fee award supports "ANTIGEN-ADJUVANT FORMULATION AND CHARACTERIZATION STUDIES" as part of NIAID's PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES program. IAVI, the prime contractor, is...
This is a $26,065,720.00 cost-plus-fixed-fee delivery order awarded to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is for the manufacture of human flu challenge material, which supports IAVI's mission to develop safe and effective preventive vaccines for infectious diseases. The award is part of IAVI's existing indefinite...